UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Full name: Elvanse 50 mg Kapsel, hård
- Invented Name Part: Elvanse
- Strength part: 50 mg
- Pharmaceutical dose form part: Kapsel, hård
Name usage: Swedish (Kingdom of Sweden)
Authorised dose form: Capsule, hard
Legal status of supply: Medicinal product subject to special medical prescription
Domain: Human use
Resource status: Current
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 47383
Region: Kingdom of Sweden
Marketing authorisation holder: Shire Pharmaceuticals Ireland Limited
Identifier:
Status: Valid (2013-07-22)
Package 1 of 1
PCID:
Description: Burk, 30 kapslar
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 1 Bottle (High Density PolyEthylene)
Containing: 30 Capsule
Manufactured Item
Dose form: Capsule, hard
Unit of presentation: Capsule
Ingredient
Role: Active
Substance: lisdexamfetamine dimesylate
Presentation strength: 50 milligram(s) / 1 Capsule
Reference strength: lisdexamfetamine 28.83 milligram(s) / 1 Capsule
Reference strength: dexamfetamine 14.8 milligram(s) / 1 Capsule